Young AL, Kellermayer R, Szigeti R et al.CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes. Clin Genet 70:246-249

Department of Dermatology, Columbia University, New York, NY 10032, USA.
Clinical Genetics (Impact Factor: 3.93). 10/2006; 70(3):246-9. DOI: 10.1111/j.1399-0004.2006.00667.x
Source: PubMed


Brooke-Spiegler syndrome (BSS), familial cylindromatosis (FC), and multiple familial trichoepithelioma (MFT), originally described as distinct inherited disorders, are characterized by a variety of skin appendage neoplasms. Mutations in the CYLD gene are found in individuals with these syndromes. We describe a single family with affected members exhibiting either the FC or the MFT phenotypes associated with a mutation in the CYLD gene. These findings support the notion that BSS, FC, and MFT represent phenotypic variation of a single defect. Of interest, one of the affected individuals described in this report exhibits a severe phenotype illustrating the morbidity of the disorder.

10 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zu den seltenen erblichen Tumorsyndromen, die sich im Kopf-Hals-Bereich manifestieren, zählen das hereditäre Paragangliom, das Gorlin-Goltz-Syndrom und die Fanconi-Anämie. Beim hereditären Paragangliom treten meist mehrere Tumoren am Glomus caroticum und/oder Glomus jugulotympanicum auf. Die korrespondierenden Gendefekte betreffen den mitochondrialen Succinat-Dehydrogenase-Komplex, der ein autonomes Tumorzellwachstum induziert. Das Gorlin-Goltz-Syndrom ist durch das Auftreten von multiplen Basalzellkarzinomen und keratozystischen odontogenen Tumoren charakterisiert. Die assoziierten Keimbahnmutationen sind im Patched-Gen lokalisiert, das einen Regulator des Zellzyklus darstellt. Bei der Fanconi-Anämie handelt es sich um ein Syndrom chromosomaler Instabilität mit primärem Knochenmarksversagen und sekundärer Entwicklung von Leukämien. Daneben treten Plattenepithelkarzinome im Kopf-Hals-Bereich, im Ösophagus und am äußeren Genitale auf. Es sind bislang 13 unterschiedliche Gendefekte bekannt, die zwei DNA-assoziierte Komplexe, welche die DNA-Reparatur steuern, betreffen. Hereditary paraganglioma, Gorlin-Goltz syndrome and Fanconi anemia are among the rare hereditary tumor syndromes of the head and neck. Patients with hereditary paraganglioma often develop multiple tumors of the glomus caroticum and glomus jugulotympanicum. The corresponding genetic defects of the mitochondrial succinate dehydrogenase complex induce autonomous tumor cell growth. In patients with Gorlin-Goltz syndrome basal cell carcinomas and keratocystic odontogenic tumors usually occur much earlier than in patients with sporadic tumors. The associated germline mutations are located in the patched gene which is a modulator of the cell cycle. Fanconi anemia represents a chromosomal instability syndrome which is characterized by early onset of pancytopenia, i.e. bone marrow failure and subsequent development of acute myeloid leukemia and/or squamous cell carcinomas, especially of the head and neck. A total of 13 different gene clusters have been identified in 2 DNA associated complexes which play an important role in DNA repair mechanisms. SchlüsselwörterHereditäres Paragangliom-Gorlin-Goltz-Syndrom-Keratozystischer odontogener Tumor-Fanconi-Anämie-Kopf-Hals-Tumor KeywordsHereditary paraganglioma-Gorlin-Goltz syndrome-Keratocystic odontogenic tumor-Fanconi anemia-Head and neck tumor
    Der Pathologe 10/2010; 31(6):477-484. DOI:10.1007/s00292-010-1359-1 · 0.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the development of new approaches to transplantation therapy, such as those building upon the potential found in stem cells, it is vital to pursue a clear understanding of transplantation risks. Allogeneic transplantation presents risk for the transmission of disease of various types, including genetic disease. Predisposition to develop cancer is a feature of numerous genetic disorders, and it may be transmissible by transplantation. Some genetic disorders predisposing to cancer are remarkably common, either worldwide or in specific populations, and they could pose significant risk. Hence, to reduce risk to recipients, there is reason to exclude from donation those potential donors (including embryos) harboring certain germ-line mutations. However, the frequent absence of readily identifiable features might confound the effort to exclude those who harbor mutation. Thus, it is also important to consider the magnitude of risk that they represent. For some disorders, life-threatening cancer is highly likely to develop in those individuals born with germ-line mutation, but whether recipients would face the same risk from transplanted mutation is not always evident. Given the diversity of pathways that lead to cancer, there may be diverse factors that impact the likelihood for cancer to develop in the recipient, with some factors decreasing and others increasing the risk. One factor of special concern is the possibility that manipulation of donor cells, prior to transplantation, might introduce additional genetic or epigenetic abnormality, thereby increasing the risk.
    Stem Cells and Development 05/2007; 16(2):191-212. DOI:10.1089/scd.2006.0080 · 3.73 Impact Factor
  • Source
    American Journal of Medical Genetics Part A 06/2007; 143A(12):1306-7. DOI:10.1002/ajmg.a.31825 · 2.16 Impact Factor
Show more